Company intelligence / Profile preview

Lendlease

Sydney, New South Wales, Australialendlease.com ↗

Ownership: Private
Development stage: Other

Overview

Lendlease has over 30 years of experience delivering pharmaceutical, biotechnology and life science facilities globally. It has constructed more than 200 projects for leading industry players across the US, APAC and Europe. In Singapore’s Tuas Biomedical Park alone it delivered two-thirds of greenfield facilities. In August 2024 it finalized a major joint venture with Warburg Pincus to focus on Asia-Pacific life science/R&D real estate development. No clinical results as it does not develop therapeutics.

Industry: Consulting

Partnerships

Ivanhoé Cambridge ($500M US-focused life sciences JV launched Feb 2022)Warburg Pincus (Asia-Pacific-focused $129M+ JV finalized Aug 2024)

Beyond the preview

Go deeper on Lendlease.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lendlease.

Explore the full profile